John Alam

Join John Alam, CEO of CervoMed and a pioneer in dementia treatment, as he shares his journey from medicine to biotech. He delves into groundbreaking advancements in addressing Dementia with Lewy Bodies and the shift toward disease-modifying therapies. John discusses the challenges of navigating clinical trials and the importance of resilience and strategic partnerships in the high-stakes world of biotech. His passion for innovation in neurodegenerative research shines through, offering a hopeful outlook for the future of dementia care.